Diffusa storcelliga B-cellslymfomOutcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of CAR T trial eligibility criteria in second-line - a population-based study of 736 patients

-Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of CAR T trial eligibility criteria in second-line - a population-based study of 736 patients

Harrysson S, Eloranta S, Ekberg S, Enblad G, El-Galaly TC, Sander B, Sonnevi K, Andersson PO,  Jerkeman M, Smedby KE

British Journal of Hematology 2022 Jul;198(2):267-277